Callan Family Office LLC Buys Shares of 7,669 The Allstate Corporation $ALL

Key Points

• Callan Family Office LLC purchased 7,669 Allstate shares during the second quarter, valued at approximately $1.825 million. Institutional investors own 76.47% of the insurer’s stock.
• Allstate reported strong quarterly results, with EPS of $8.99 versus the $6.06 analyst consensus and revenue of $18.60 billion, up 11.8% year over year.
• Investor sentiment is mixed: Allstate announced a $1.08 quarterly dividend, while analysts cited catastrophe losses, including $682 million in July, and issued conflicting ratings. The consensus rating remains “Hold,” with an average price target of $265.26.

Callan Family Office LLC purchased a new stake in The Allstate Corporation (NYSE:ALL - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 7,669 shares of the insurance provider's stock, valued at approximately $1,825,000.

Several other large investors have also recently made changes to their positions in the stock. Gables Capital Management Inc. purchased a new stake in shares of Allstate during the second quarter valued at about $26,000. Allied Private Wealth LLC bought a new stake in shares of Allstate in the 2nd quarter valued at about $29,000. Kelleher Financial Advisors purchased a new position in shares of Allstate in the 2nd quarter worth approximately $28,000. MV Capital Management Inc. bought a new position in shares of Allstate during the 4th quarter worth approximately $25,000. Finally, Navalign LLC bought a new position in shares of Allstate during the 4th quarter worth approximately $27,000. 76.47% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 32,996 shares of Allstate stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the completion of the sale, the insider owned 13,054 shares of the company's stock, valued at approximately $3,515,833.82. The trade was a 71.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Andrea Redmond sold 2,225 shares of the business's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the sale, the director owned 2,225 shares in the company, valued at approximately $451,474.75. The trade was a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 91,446 shares of company stock worth $24,208,675 in the last 90 days. Insiders own 1.55% of the company's stock.

More Allstate News

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Stock Down 0.0%

NYSE:ALL opened at $253.82 on Monday. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The Allstate Corporation has a twelve month low of $188.08 and a twelve month high of $277.22. The company has a market cap of $64.18 billion, a PE ratio of 5.07, a P/E/G ratio of 0.39 and a beta of 0.16. The company's 50 day moving average is $250.34 and its two-hundred day moving average is $225.12.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The business had revenue of $18.60 billion during the quarter, compared to analysts' expectations of $15.46 billion. During the same quarter last year, the company posted $5.94 earnings per share. The business's quarterly revenue was up 11.8% on a year-over-year basis. Analysts anticipate that The Allstate Corporation will post 34.45 EPS for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be paid a $1.08 dividend. The ex-dividend date is Monday, August 31st. This represents a $4.32 dividend on an annualized basis and a yield of 1.7%. Allstate's dividend payout ratio (DPR) is 8.63%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ALL. Keefe, Bruyette & Woods restated an "underperform" rating and issued a $250.00 target price (down from $255.00) on shares of Allstate in a research note on Thursday. Zacks Research upgraded Allstate from a "hold" rating to a "strong-buy" rating in a report on Monday, August 17th. Roth Capital set a $300.00 price objective on Allstate in a report on Thursday, August 6th. Weiss Ratings raised Allstate from a "buy (a-)" rating to a "buy (a)" rating in a research report on Thursday, August 6th. Finally, Wall Street Zen upgraded Allstate from a "hold" rating to a "buy" rating in a research note on Monday, July 20th. Four investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have issued a Hold rating and four have assigned a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $265.26.

Allstate Company Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source